graphic
News > Deals
Bergen Brunswig expands
January 11, 1999: 10:53 a.m. ET

Drug distributor buying PharMerica, supplier to nursing homes, for $1.4B
graphic
graphic graphic
graphic
NEW YORK (CNNfn) -- Bergen Brunswig Corp., the pharmaceutical and medical-surgical supply distributor, is continuing a buying spree with the $1.4 billion acquisition of PharMerica Inc., a Tampa, Fla.-based provider of pharmaceuticals to long-term care and alternate site health services.
     Under terms of the agreement, Orange, Calif.-based Bergen Brunswig (BBC) will swap 0.275 share of its common stock for each PharMerica (DOSE) share tendered. Friday's closing price of $32.50 for Bergen Brunswig stock values PharMerica at about $8.94 a share, well above its $6.50 a share close Friday.
     Bergen Brunswig also says it will issue about 25 million shares as part of the merger and will convert PharMerica stock options into Bergen Brunswig options at the swap rate. Bergen Brunswig will assume about $580 million in PharMerica debt.
     PharMerica, with 89.7 million fully diluted shares outstanding, will own about 18 percent of Bergen Brunswig once the transaction is completed.
     PharMerica has annual sales of about $1.2 billion, compared with the $17.1 billion in sales of Bergen Brunswig. Its services affect about 500,000 patients, mostly older Americans being cared for in nursing homes, assisted living facilities, specialty hospitals and in their homes.
     Bergen Brunswig says the definitive agreement is subject to regulatory approvals and expects to complete the deal in the second quarter of 1999.
     "This transaction further accelerates our earnings growth and is expected to raise our EBITDA margins by over 40 percent," says Bergen Brunswig President Donald Roden, citing 22 percent growth in the company's earnings in fiscal 1998, ended Sept. 30.
     The company says the transaction builds on the acquisition of Statlander, a specialty care provider of treatment to prisons and patients suffering HIV or undergoing transplant, psychological or infertility therapies.
     The deal also follows on the heels of the $100 million acquisition of BayCare Health System, a chain of hospitals in the Tampa area, that was announced last week. Back to top

  RELATED STORIES

Bergen mixes specialty drugs - Nov. 9, 1998

Drug deals canceled - Aug. 7, 1998

  RELATED SITES

Bergen Brunswig

PharMerica


Note: Pages will open in a new browser window
External sites are not endorsed by CNNmoney




graphic

© 2009 Cable News Network. A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy. Advertising Practices.
Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data.
Fundamental data provided by Morningstar, Inc..
SEC Filings data provided by Edgar Online Inc..
Earnings data provided by FactSet CallStreet, LLC.